Table 3.
Potential advantages and disadvantages of biodegradable-based stents (Bourantas et al. 2013; Kereiakes et al. 2016; Onuma and Serruys 2011; Sharkawi et al. 2007)
Potential advantages | |
Restoration of cyclic pulsatility and normal vasomotion | Prevented acute occlusion |
Prevented acute ST and subacute ST | Restoration of normal vessel curvature |
Normalizing shear stress and cyclic strain | Prevented acute recoil |
Prevented constrictive remodeling | Prevented expansive remodeling |
Reduced risk of very late polymer reactions | Avoidance of stent malapposition |
Reduced neoatherosclerosis | Avoidance of late luminal enlargement |
Avoidance of late vessel wall inflammation | Prevented neointimal hyperplasia |
Prevented late ST | Formation of a cap over lipid-rich plaque |
Unjailing of side branches | |
Disadvantages | |
Unsuitable release profile for drug delivery system | Difficulty in delivery to the site of action because of thicker struts with larger crossing profile |
Greater risk of acute strut fracture as a result of insufficient mechanical strength compared with metallic DES | Inadequate degradation and resorption profile |
Increased rates of early thrombosis | Inflammatory degradation residues |
Specific (cold) storage condition and specific deployment techniques |